Guidelines: NCCN Guidelines (Poland): Difference between revisions
m (Victor moved page NCCN Guidelines (Poland) to Guidelines: NCCN Guidelines (Poland)) |
m (Update categories.) |
||
| Line 53: | Line 53: | ||
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | <span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | ||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | <span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | ||
<span style="display:none">isPracticeGuideline</span> | |||
Revision as of 16:43, 4 December 2025
Go back to Poland page
Primary purpose: To assist clinicians in determining appropriate and effective avenues of care.
Sponsor, manager or home institution: National Comprehensive Cancer Network (NCCN) and Norodowy Intytut Onkologii.
Type of information: It contains clinical recommendations, treatments, follow up, quality of life, of breast cancer, colon cancer, melanoma, non-small cell lung cancer, prostate cancer and squamous cell skin cancer.
Cancer areas of interest: C50: Breast cancer,C15-C26: Digestive system cancers, C43-C44: Skin cancers/melanoma, C30-C39: Lung/chest cancers, C60-C63: Male genitalia cancer. Click here to learn more
Access to information: Click here to access, in European editions: Poland (Is necessary to create a login to access the information).